预测结肠直肠癌患者的生存率:多基因生存率评分的开发和验证
Rawan M Maawadh1, Chao Xu2, Rizwan Ahmed3
1Clinical Laboratory Science Department, Prince Sultan Military College of Health Science, Dammam, Saudi Arabia.
Clinical and experimental gastroenterology
|October 21, 2024
概括
这项研究开发了一种多基因生存评分系统 (PSS) 来预测结直肠癌的生存率. 该PSS准确地识别出高死亡风险的患者,帮助未来的研究和治疗策略.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 结肠直肠癌是癌症死亡的主要原因之一.
- 多omics方法揭示了癌症突变和细胞反应.
- 确定生存预测因素对于患者的治疗结果至关重要.
研究的目的:
- 为了确定与结直肠癌存活率相关的因素.
- 开发和验证使用多omics数据的多基因生存评分系统 (PSS).
主要方法:
- 利用癌症基因组图谱 (TCGA) 的数据用于结肠 (TCGA-COAD) 和直肠 (TCGA-READ) 腺癌.
- 采用Cox比例危险回归来分析人口统计,临床和基因表达数据.
- 开发并验证了用于结直肠癌生存预测的PSS.
主要成果:
- 确定了年龄,癌症阶段和9个基因表达作为结肠癌存活率的预测因素.
- 该PSS在预测结直肠癌存活率方面表现出高准确性.
- 低PSS得分的患者的5年生存率明显更高.
结论:
- 综合临床和转录组数据,以确定关键的生存预测因素.
- PSS是估计结肠直肠癌存活率的验证和准确工具.
- 该PSS可以为未来的结直肠癌研究和临床应用做出重大贡献.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
Kaplan-Meier Approach
102
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
102
Survival Curves
106
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
106
Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63


